Andover, Mass.
Pfizer broke ground in June of 2016 on a $200 million clinical manufacturing facility for complex biologics and vaccines in Andover, Mass. The five-story, 175,000-sf facility is expected to be fully operational by January of 2019 and will accommodate 75 employees. Designed for maximum flexibility, the project will feature five independent production suites that utilize next-generation manufacturing strategies including single-use bioreactors and disposable process technologies.
Source
